74 related articles for article (PubMed ID: 10880255)
41. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis.
Anscher MS; Kong FM; Marks LB; Bentel GC; Jirtle RL
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):253-8. PubMed ID: 9069294
[TBL] [Abstract][Full Text] [Related]
42. Increased levels of transforming growth factor-beta1 in essential hypertension.
Derhaschnig U; Shehata M; Herkner H; Bur A; Woisetschläger C; Laggner AN; Hirschl MM
Am J Hypertens; 2002 Mar; 15(3):207-11. PubMed ID: 11939608
[TBL] [Abstract][Full Text] [Related]
43. Serum and urine interleukin-6 and transforming growth factor-beta1 in young infants with pyelonephritis.
Galanakis E; Bitsori M; Dimitriou H; Giannakopoulou C; Karkavitsas NS; Kalmanti M
Int Urol Nephrol; 2007; 39(2):581-5. PubMed ID: 17318354
[TBL] [Abstract][Full Text] [Related]
44. Relationship of Transforming Growth Factor-βl and Arginase-1 Levels with Long-term Survival after Kidney Transplantation.
Du XX; Guo YL; Yang M; Yu Y; Chang S; Liu B; Cai LJ; Chen ZK
Curr Med Sci; 2018 Jun; 38(3):455-460. PubMed ID: 30074212
[TBL] [Abstract][Full Text] [Related]
45. Transforming growth factor beta-1 An important biomarker for developing cardiovascular diseases in chronic renal failure.
Avci E; Avci GA; Ozcelik B; Cevher SC; Suicmez M
Bratisl Lek Listy; 2017; 118(3):175-178. PubMed ID: 28319415
[TBL] [Abstract][Full Text] [Related]
46. [The use of plasmapheresis in treating urology patients].
Neĭmark AI; Astakhov IuI; Davydov AV; Mazyrko AV; Iakovets IaV
Ter Arkh; 1993; 65(10):83-6. PubMed ID: 8296244
[TBL] [Abstract][Full Text] [Related]
47. [Behavior of erythropoietin serum level in various kidney diseases].
Heilmann E
Verh Dtsch Ges Inn Med; 1973; 79():451-3. PubMed ID: 4597612
[No Abstract] [Full Text] [Related]
48. [Potassium concentration in plasma and erythrocytes in kidney patients].
Schoeppe W; Brecht HM
Med Klin; 1969 Apr; 64(17):781-5. PubMed ID: 5785369
[No Abstract] [Full Text] [Related]
49. [The level of beta-lysines in serum as an indicator of activity of the inflammatory process].
Buglova SE; Levin VI; Buglova AE
Lab Delo; 1989; (9):18-21. PubMed ID: 2481121
[TBL] [Abstract][Full Text] [Related]
50. Serum complement level in renal diseases.
Bober S; Bragiel I; Tyszkiewicz Z
Pol Med J; 1966; 5(4):744-8. PubMed ID: 5964893
[No Abstract] [Full Text] [Related]
51. [Importance of the tesigraphic method of urine analysis].
Kalikshteĭn DB; Moroz LA; Cherniakov VL
Lab Delo; 1981; (2):79-81. PubMed ID: 6163919
[No Abstract] [Full Text] [Related]
52. [Chronic renal insufficiency. Elevated levels of the active metabolite (3-hydroxyquinidine) of quinidine].
Camsonne R; Moulin MA; Ryckelynck JP; Mignot P; Albessard F; Perault M; Bigot MC; Richard O
Nouv Presse Med; 1982 Oct; 11(41):3062-3. PubMed ID: 7145692
[No Abstract] [Full Text] [Related]
53. The renal peristaltic cycle and neuromuscular aspects of renal function and their relationship to diseases of the kidney.
HATZ B
Ann Intern Med; 1950 May; 32(5):971-82. PubMed ID: 15413918
[No Abstract] [Full Text] [Related]
54. Kidney cancer: Are we overclassifying renal cancer?
Fenner A
Nat Rev Urol; 2010 Dec; 7(12):646. PubMed ID: 21188775
[No Abstract] [Full Text] [Related]
55. A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma.
DeBenedette M; Gamble A; Norris M; Horvatinovich J; Nicolette CA
Hum Vaccin Immunother; 2023 Aug; 19(2):2220629. PubMed ID: 37387210
[TBL] [Abstract][Full Text] [Related]
56. Downregulation of the endothelial histone demethylase JMJD3 is associated with neointimal hyperplasia of arteriovenous fistulas in kidney failure.
Feng S; Peden EK; Guo Q; Lee TH; Li Q; Yuan Y; Chen C; Huang F; Cheng J
J Biol Chem; 2022 May; 298(5):101816. PubMed ID: 35278430
[TBL] [Abstract][Full Text] [Related]
57. Can Tumor Necrosis Factor- α and Interleukin-6 Be Used as Prognostic Markers of Infection following Ureteroscopic Lithotripsy?
Bantis A; Tsakaldimis G; Zissimopoulos A; Giannakopoulos S; Kalaitzis C; Pitiakoudis M; Polichronidis A; Touloupidis S
ISRN Urol; 2014; 2014():457063. PubMed ID: 24605247
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of TGF-β1, CCL5/RANTES and sFas/Apo-1 urine concentration in children with ureteropelvic junction obstruction.
Gawłowska-Marciniak A; Niedzielski JK
Arch Med Sci; 2013 Oct; 9(5):888-94. PubMed ID: 24273575
[TBL] [Abstract][Full Text] [Related]
59. Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux.
Sabasiñska A; Zoch-Zwierz W; Wasilewska A; Porowski T
Pediatr Nephrol; 2008 May; 23(5):769-74. PubMed ID: 18288503
[TBL] [Abstract][Full Text] [Related]
60. Transforming growth factor-beta downregulates interleukin-2-induced phosphorylation of signal transducer and activator of transcription 5 in human renal cell carcinoma.
Song C; Jun SY; Hong JH; Ahn H
J Cancer Res Clin Oncol; 2007 Jul; 133(7):487-92. PubMed ID: 17279417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
